Skip to main content

Is Lenskart\

By MoneyCal Editorial TeamPublished 2026

Table of Contents

What's New

While the Lenskart growth story is undeniably attractive, a thorough audit of the preliminary Draft Red Herring Prospectus (DRHP) and comparative market data reveals 10 critical risk factors that every retail investor must weigh: (1) The Valuation Gravity Risk: At a 13.5x revenue multiple, Lenskart is trading at a massive premium to global leader Warby Parker (2x) and domestic incumbent Titan EyePlus (3x). If growth slows even marginally, this valuation multiple could collapse to 6x-8x within months, leading to a 50% price correction. (2) Low Promoter Holding and Skin-in-the-Game: Post-IPO, the founders

Why It Matters

Investing in an IPO is an act of asymmetric risk—you are capped by the price discovery on listing day but have a potential 100% downside if the business model fails. For Lenskart, the

  • "Principal Risk: A 40-50% drawdown is statistically probable if the company misses its first two quarterly revenue targets post-listing.
  • Valuation Compression: If global interest rates stay high, growth multiples like Lenskart's 13.5x will naturally settle toward 6x-8x, cutting share value in half.
  • Founder Commitment: Low promoter holding (27%) might lead to a 'Professionalized but Disengaged' management style compared to high-stake founders.
  • Titan's Market Share Erosion: TATA's entry into the budget segment could force Lenskart into a margin-destroying price war in Tier-3 cities.
  • International Asset Write-offs: Failure to scale in Japan (Owndays) or Thailand could lead to hundreds of crores in impairments and bad-will.
  • Regulatory Drag: Increased SEBI scrutiny on 'New Age Technology Companies' might result in stricter reporting and lower operational flexibility.
  • ESOP Selling Pressure: Significant post-listing selling by 4,000+ employees could create a massive 'Overhang' on the stock price for 12-24 months.
  • Retail Wealth Erosion: Millions of retail investors potentially entering at 'Peak Valuation' could be stuck in a 'Down-cycle' for 3-5 years.
  • Advertising Cost Spike: As customer acquisition becomes harder in saturated metros, marketing spend might rise back to 15% of revenue, eating profits.
  • Platform Risk: Heavy reliance on Amazon/Flipkart for online sales (outside their own app) makes them vulnerable to changes in marketplace algorithms."
Advertisement

The Valuation Gravity: Why 13.5x is a Dangerous Peak

Breaking down the

Advertisement

Key Facts & Data

Revenue Multiple (EV/Sales) 13.5x (vs Warby Parker 2.1x, Titan 3.2x)
Promoter Holding Post-IPO 27.2% (Estimated)
Institutional Holding (PE/VC) 60.5% (Pre-IPO)
International Losses (FY24) ₹620 Crore (Consolidated)
Titan EyePlus Expansion 500 Stores/Year Target
Working Capital Cycle 65 Days
Debt-to-Equity Ratio 0.18 (Low but rising)
CAC-to-LTV Ratio 1:2.8 (Healthy but decreasing)
R&D/Tech Spend to Revenue 12% (Significantly high)
Nifty Small/Mid-cap P/E 22.5x (Historical peak)
Ad-Spend Efficiency Dropped 15% in FY24
Store Payback (Tier-1) 18 Months
Advertisement

Key Takeaways

  • "The ₹70,000 crore valuation target leaves almost no 'Margin of Safety' for retail investors.
  • Don't be blinded by founder celebrity status—focus on the cold, hard numbers in the DRHP.
  • Compare Lenskart with Titan EyePlus for a more realistic view of retail valuations in India.
  • Be prepared for a 'Time Correction'—even if the company performs, the stock might stay flat as earnings catch up.
  • Understand the difference between Revenue growth and Profit growth—Lenskart is still chasing the latter.
  • If you choose to apply, keep your allocation small (below 5% of your equity portfolio)."